ATE357923T1 - Behandlung der osteoporose - Google Patents

Behandlung der osteoporose

Info

Publication number
ATE357923T1
ATE357923T1 AT01983322T AT01983322T ATE357923T1 AT E357923 T1 ATE357923 T1 AT E357923T1 AT 01983322 T AT01983322 T AT 01983322T AT 01983322 T AT01983322 T AT 01983322T AT E357923 T1 ATE357923 T1 AT E357923T1
Authority
AT
Austria
Prior art keywords
pentosan polysulfate
pps
pentosan
treatment
osteoporosis
Prior art date
Application number
AT01983322T
Other languages
English (en)
Inventor
David Cullis-Hill
Original Assignee
Arthropharm Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arthropharm Pty Ltd filed Critical Arthropharm Pty Ltd
Application granted granted Critical
Publication of ATE357923T1 publication Critical patent/ATE357923T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT01983322T 2000-11-21 2001-11-19 Behandlung der osteoporose ATE357923T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/716,818 US6593310B1 (en) 2000-11-21 2000-11-21 Treatment of osteoporosis

Publications (1)

Publication Number Publication Date
ATE357923T1 true ATE357923T1 (de) 2007-04-15

Family

ID=24879564

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01983322T ATE357923T1 (de) 2000-11-21 2001-11-19 Behandlung der osteoporose

Country Status (9)

Country Link
US (1) US6593310B1 (de)
EP (1) EP1335733B1 (de)
JP (1) JP2004513185A (de)
CN (1) CN1476328A (de)
AT (1) ATE357923T1 (de)
AU (1) AU2002214835A1 (de)
CA (1) CA2426929A1 (de)
DE (1) DE60127575T2 (de)
WO (1) WO2002041901A1 (de)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050070504A1 (en) * 2001-12-21 2005-03-31 The Procter & Gamble Co. Risedronate compositions and their methods of use
AU2003255232A1 (en) * 2002-08-07 2004-02-25 University Of Mississippi Antigiardial agents and use thereof
US20060068036A1 (en) * 2002-12-31 2006-03-30 National Yang-Ming University Extract of Dioscorea sp. and the medical uses thereof
US20040126447A1 (en) * 2002-12-31 2004-07-01 Rong-Tsun Wu Extract of Dioscorea sp. and the medical uses thereof
US8668908B2 (en) * 2002-12-31 2014-03-11 National Yang-Ming University Method for alleviating chemotherapy side effects using extract of Dioscorea sp
US7553827B2 (en) * 2003-08-13 2009-06-30 Depuy Spine, Inc. Transdiscal administration of cycline compounds
US7344716B2 (en) * 2003-05-13 2008-03-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
US7429378B2 (en) * 2003-05-13 2008-09-30 Depuy Spine, Inc. Transdiscal administration of high affinity anti-MMP inhibitors
US8273347B2 (en) 2003-05-13 2012-09-25 Depuy Spine, Inc. Autologous treatment of degenerated disc with cells
US20040229878A1 (en) * 2003-05-13 2004-11-18 Depuy Spine, Inc. Transdiscal administration of specific inhibitors of P38 kinase
US8361467B2 (en) 2003-07-30 2013-01-29 Depuy Spine, Inc. Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
US8895540B2 (en) * 2003-11-26 2014-11-25 DePuy Synthes Products, LLC Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
US8202546B2 (en) 2005-08-04 2012-06-19 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US7998500B2 (en) 2005-08-04 2011-08-16 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
US7901710B2 (en) 2005-08-04 2011-03-08 Vertical Pharmaceuticals, Inc. Nutritional supplement for use under physiologically stressful conditions
US8263137B2 (en) 2005-08-04 2012-09-11 Vertical Pharmaceuticals, Inc. Nutritional supplement for women
MXPA05014091A (es) * 2005-12-20 2007-06-20 Leopoldo De Jesus Espinosa Abdala Composiciones farmaceuticas que comprenden derivados de esteroides sinteticos, minerales y el metabolito activo de la vitamina d, 1,25(oh)2d3 (calcitriol) para la prevencion y tratamiento de la osteoporosis y el control de los sintomas de la menopaus
US20080076723A1 (en) * 2006-09-27 2008-03-27 Sylvan Pharmaceuticals Pty Ltd. Inhibition of cathepsin K activity and the treatment and prevention of disease
JPWO2008102568A1 (ja) * 2007-02-22 2010-05-27 株式会社Ｐｇリサーチ 骨軟骨形成促進剤
US8986696B2 (en) * 2007-12-21 2015-03-24 Depuy Mitek, Inc. Trans-capsular administration of p38 map kinase inhibitors into orthopedic joints
AU2008100730B4 (en) * 2008-07-04 2008-10-02 Parnell Technologies Pty Ltd Sulfated polysaccharide compound for clinical use and the preparation thereof
US8273393B2 (en) * 2008-07-09 2012-09-25 Melaleuca, Inc. Mineral amino acid polysaccharide complex
TWI520740B (zh) 2011-02-02 2016-02-11 模範健康科技私人企業有限公司 利用多硫酸化多醣之骨髓水腫（水腫）的治療
CN102988679A (zh) * 2012-10-16 2013-03-27 杨晓兵 一种益肾健脾防治骨质疏松的药物组合物
MX2020002288A (es) 2016-08-31 2020-07-14 Oji Holdings Corp Metodo de produccion para xilooligosacarido acido y xilooligosacarido acido.
JP6225321B1 (ja) 2016-08-31 2017-11-08 王子ホールディングス株式会社 ポリ硫酸ペントサンの製造方法
JP6281659B1 (ja) 2017-02-28 2018-02-21 王子ホールディングス株式会社 ポリ硫酸ペントサン、医薬組成物及び抗凝固剤
KR20240023711A (ko) 2017-05-31 2024-02-22 오지 홀딩스 가부시키가이샤 보습 외용제
NZ761962A (en) * 2017-08-04 2023-04-28 Paradigm Biopharmaceuticals Ltd Treatment of bone marrow pathologies with polysulfated polysaccharides
MX2020002726A (es) 2017-09-12 2020-07-20 Oji Holdings Corp Polisulfato de pentosan y metodo para producir polisulfato de pentosan.
HUE062342T2 (hu) 2017-12-20 2023-10-28 Oji Holdings Corp Pentozán-poliszulfát, valamint pentozán-poliszulfátot tartalmazó gyógyszerek
KR20210003087A (ko) 2018-02-28 2021-01-11 패러다임 바이오파마슈티컬스 리미티드 다황화된 다당류를 이용한 수술 후 관절통의 치료
CN115671129A (zh) * 2018-06-11 2023-02-03 广西壮族自治区中国科学院广西植物研究所 木聚糖在制备预防或治疗骨质疏松的药物或食品中的应用
SG11202103319SA (en) 2018-10-10 2021-04-29 Paradigm Biopharmaceuticals Ltd Treatment of pain with polysulfated polysaccharides

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE364636B (de) * 1968-01-16 1974-03-04 S Ericsson
EP0356435B1 (de) * 1987-03-19 1995-10-18 Arthropharm Pty. Limited Antientzündungsmittel und zusammensetzungen
FR2691066B1 (fr) * 1992-05-15 1995-06-09 Sanofi Elf Utilisation de glycosaminoglycanes exogenes, de leurs analogues ainsi que de leurs fragments, fractions et derives, pour la preparation de medicaments destines au traitement de thrombopenies.
EP1127578A4 (de) * 1998-10-28 2004-12-15 Sankyo Co Heilmittel für knochenmetabolische abweichungen

Also Published As

Publication number Publication date
DE60127575D1 (de) 2007-05-10
JP2004513185A (ja) 2004-04-30
EP1335733A4 (de) 2006-03-22
AU2002214835A1 (en) 2002-06-03
EP1335733B1 (de) 2007-03-28
US6593310B1 (en) 2003-07-15
CA2426929A1 (en) 2002-05-30
DE60127575T2 (de) 2007-12-06
EP1335733A1 (de) 2003-08-20
WO2002041901A1 (en) 2002-05-30
CN1476328A (zh) 2004-02-18

Similar Documents

Publication Publication Date Title
DE60127575D1 (de) Behandlung der osteoporose
MX9304435A (es) Compuesto y composicion farmaceutica para el tratamiento y la profilaxis de la obesidad o para el tratamiento de la diabetes del tipo ii.
DOP2004001052A (es) Inhibidores heterociclil amino de 11-beta-hidroxiesteroide deshidrogenasa tipo 1
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
WO2003057225A3 (en) Phosphate transport inhibitors
EA199900239A1 (ru) Замещенные n-[аминоиминометил или аминометил) фенил] пропиламиды
MEP28208A (en) Pharmaceutical formulations and use thereof in the prevention of stroke, diabetes and/or congestive heart failure
BR0317463A (pt) Métodos de triar para um composto que evita ou reduz a dissolução de um tetrâmero de transtiretina e de tratar uma doença amilóide transtiretina
PT927217E (pt) Compostos inibidores angiogenicos
RU94044671A (ru) Применение непептидных антагонистов рецептора тахикинина
RU98100107A (ru) Замещенные липосахариды, используемые для лечения и профилактики эндотоксикоза
RU94036758A (ru) Применение 2-фенил-3-ароилбензотиофенов для лечения пери-менопаузного синдрома
ATE309999T1 (de) Blutplättchen-adp-rezeptor-inhibitoren
EA199800290A1 (ru) (метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
CO5280060A1 (es) Aminoacidos biciclicos como agentes farmaceuticos
WO2000049007A8 (en) Acetamido acetonitrile derivatives as inhibitors of cathepsin l and/or cathepsin s
ES2120728T3 (es) Inhibidores de la agregacion de plaquetas.
ES2157252T3 (es) Aplicacion del riluzol en el tratamiento del neuro-sida.
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
RU94045278A (ru) Применение 2-фенил-3-ароилбензтиофенов для ингибирования вазомоторных симптомов и сопутствующих психологических нарушений, ассоциированных с постклимактерическим синдромом
EA199901075A1 (ru) Лечение резистентности к инсулину средствами, стимулирующими секрецию гормона роста
KR950014067A (ko) 아릴아미드유도체
RU94044356A (ru) Применение 2-фенил-3-ароилбензотиофенов для увеличения экспрессии тромбомодулина для ингибирования тромботического расстройства, для увеличения активации протеина с
MX2022009967A (es) Compuestos para el tratamiento de la infeccion por coronavirus.
DE69029693D1 (de) Hydantoin- oder Imidazolidintrionderivate zur Vorbeugung oder Behandlung von Niereninsuffizienz

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties